Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Veliparib

EU orphan designation number: EU/3/10/830   
Active ingredient: Veliparib
Indication: Treatment of ovarian cancer
Sponsor: AbbVie Ltd
Maidenhead, SL6 4XE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Centralised Orphan - Designation EMA/OD/110/10 (2010)9543 of 17/12/2010
01/02/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/110/10/T/01 (2013)598 of 30/01/2013